In 2010, Biofarm’s shareholders received a gross dividend of RON0.0055 a share.
The proposal is subject to shareholder approval at a meeting due April 23. If cleared, the pharmaceuticals company will pay out total dividends of RON11 million, equal to 75% of last year’s net profit of RON14.5 million.
Biofarm has a share capital of RON109.4 million split into 1.09 billion shares with a face value of RON0.1.
Romanian regional investment funds SIF Oltenia (SIF5.RO), SIF Banat Crisana (SIF1.RO) and SIF Moldova (SIF2.RO) own together around 54% of Biofarm’s shares.
Tuesday, Biofarm’s shares closed down 2% to RON0.196 in Bucharest. (EUR1=RON4.378)